Assessment of physical activity during and post allogenic haematopoetic cell transplantation

Assessment of physical activity during and post allogenic haematopoetic cell transplantation - alloActiv-Pilot

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004342

Enrollment

Registered

2013-01-04

Start date

2013-01-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing allogeneic haematopoetic cell transplantation (HCT) C81-C96

Interventions

Group 1: Patients untergoing allogeneic stem cell transplantation will receive an accelerometer on the day of admission that records patients` activity level for the duration of their hospitalisation.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - adult patients undergoing alloHCT (18 years old) - patient's information followed by written consent

Exclusion criteria

Exclusion criteria: non

Design outcomes

Primary

Measure	Time frame
- activity-time per activity-category (min/day) measured among the inpatient period of time during alloHCST (approx. 40 days) with a three-dimensional accelerometer (Aipermon 440 PC, Aipermon GmbH & Co.KG, München)	—

Secondary

Measure	Time frame
- walking-distance (m/day) measured by a three-dimensional accelerometer (Aipermon 440 PC, Aipermon GmbH & Co.KG, München) - physical activity level (metabolic equivalent of task [MET]) per week before and during therapy start measured by a questionnaire for phyical activity [FFKA: Freiburger Fragebogen zur körperlichen Aktivität] - body composition measured by body-impedance-analysis (°, %, kg) (Nutrigard MS®, Data Input GmbH, Darmstadt) - muscle size m. quadriceps femoris (cm) measured by sonography (Siemens Sonoline G40, 10.5.MHz, Germany) - blood parameter documentation	—

Measure

Time frame

- walking-distance (m/day) measured by a three-dimensional accelerometer (Aipermon 440 PC, Aipermon GmbH & Co.KG, München) - physical activity level (metabolic equivalent of task [MET]) per week before and during therapy start measured by a questionnaire for phyical activity [FFKA: Freiburger Fragebogen zur körperlichen Aktivität] - body composition measured by body-impedance-analysis (°, %, kg) (Nutrigard MS®, Data Input GmbH, Darmstadt) - muscle size m. quadriceps femoris (cm) measured by sonography (Siemens Sonoline G40, 10.5.MHz, Germany) - blood parameter documentation

—

Countries

Germany

Contacts

Public ContactAnja Wehrle

Universitätsklinik FreiburgDepartment Innere MedizinInstitut für Bewegungs- und Arbeitsmedizin

anja.wehrle@uniklinik-freiburg.de0761/270-74930

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026